Literature DB >> 10878666

X inactivation phenotype in carriers of Pelizaeus-Merzbacher disease: skewed in carriers of a duplication and random in carriers of point mutations.

K Woodward1, K Kirtland, S Dlouhy, W Raskind, T Bird, S Malcolm, D Abeliovich.   

Abstract

Pelizaeus-Merzbacher disease (PMD) is an X-linked recessive disease caused by coding sequence mutations in the PLP gene, sub-microscopic duplications of variable sizes including the PLP gene or very rarely deletions of the PLP gene. We analysed the X inactivation pattern in blood of PMD female carriers with duplications and with point mutations. In the majority of duplication carriers (7/11), the X chromosome bearing the duplication was preferentially inactivated, whereas a random pattern of X inactivation was detected in point mutation carriers (3/3), a deletion carrier (1/1), affected females (4/4) who did not have a recognised mutation and normal control females. However 2/5 non-carrier female relatives of patients with a duplication, had skewed X inactivation. The skewed pattern of inactivation observed in most duplication carriers and not in mutation carriers suggests a) that there is selection against those cells in which the duplicated X chromosome is active and b) other expressed sequences within the duplicated region rather than mutant PLP may be responsible. Since the skewed X inactivation did not segregate with the disease in two families and the pattern of X inactivation was variable among the duplication carriers, the pattern X inactivation is an unsuitable diagnostic tool for female carriers of PMD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10878666     DOI: 10.1038/sj.ejhg.5200480

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  12 in total

1.  Evidence for disease penetrance relating to CNV size: Pelizaeus-Merzbacher disease and manifesting carriers with a familial 11 Mb duplication at Xq22.

Authors:  C M B Carvalho; M Bartnik; D Pehlivan; P Fang; J Shen; J R Lupski
Journal:  Clin Genet       Date:  2011-06-20       Impact factor: 4.438

2.  Heterogeneous duplications in patients with Pelizaeus-Merzbacher disease suggest a mechanism of coupled homologous and nonhomologous recombination.

Authors:  Karen J Woodward; Maria Cundall; Karen Sperle; Erik A Sistermans; Mark Ross; Gareth Howell; Susan M Gribble; Deborah C Burford; Nigel P Carter; Donald L Hobson; James Y Garbern; John Kamholz; Henry Heng; M E Hodes; Sue Malcolm; Grace M Hobson
Journal:  Am J Hum Genet       Date:  2005-10-19       Impact factor: 11.025

Review 3.  PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2.

Authors:  Ken Inoue
Journal:  Neurogenetics       Date:  2004-12-31       Impact factor: 2.660

4.  Exon array CGH: detection of copy-number changes at the resolution of individual exons in the human genome.

Authors:  Pawandeep Dhami; Alison J Coffey; Stephen Abbs; Joris R Vermeesch; Jan P Dumanski; Karen J Woodward; Robert M Andrews; Cordelia Langford; David Vetrie
Journal:  Am J Hum Genet       Date:  2005-03-08       Impact factor: 11.025

5.  A large X-chromosomal deletion is associated with microphthalmia with linear skin defects (MLS) and amelogenesis imperfecta (XAI).

Authors:  Grace M Hobson; Carolyn W Gibson; Melissa Aragon; Zhi-an Yuan; Angelique Davis-Williams; Linda Banser; Jennifer Kirkham; Alan H Brook
Journal:  Am J Med Genet A       Date:  2009-08       Impact factor: 2.802

Review 6.  Neurogenetics of Pelizaeus-Merzbacher disease.

Authors:  M Joana Osório; Steven A Goldman
Journal:  Handb Clin Neurol       Date:  2018

7.  Elucidation of the pathogenic mechanism and potential treatment strategy for a female patient with spastic paraplegia derived from a single-nucleotide deletion in PLP1.

Authors:  Keiko Yamamoto-Shimojima; Taichi Imaizumi; Yusuke Aoki; Ken Inoue; Tadashi Kaname; Yusuke Okuno; Hideki Muramatsu; Kohji Kato; Toshiyuki Yamamoto
Journal:  J Hum Genet       Date:  2019-04-19       Impact factor: 3.172

8.  PLP1 mutations and central demyelination: Evidence from electrophysiologic phenotyping in female manifesting carriers.

Authors:  Michael J Keogh; Stephan R Jaiser; Hannah E Steele; Rita Horvath; Patrick F Chinnery; Mark R Baker
Journal:  Neurol Clin Pract       Date:  2017-10

9.  Molecular genetic analysis of the PLP1 gene in 38 families with PLP1-related disorders: identification and functional characterization of 11 novel PLP1 mutations.

Authors:  Serena Grossi; Stefano Regis; Roberta Biancheri; Matthew Mort; Susanna Lualdi; Enrico Bertini; Graziella Uziel; Odile Boespflug-Tanguy; Alessandro Simonati; Fabio Corsolini; Ercan Demir; Valentina Marchiani; Antonio Percesepe; Franco Stanzial; Andrea Rossi; Catherine Vaurs-Barrière; David N Cooper; Mirella Filocamo
Journal:  Orphanet J Rare Dis       Date:  2011-06-16       Impact factor: 4.123

10.  Insertion of an extra copy of Xq22.2 into 1p36 results in functional duplication of the PLP1 gene in a girl with classical Pelizaeus-Merzbacher disease.

Authors:  Julien Masliah-Planchon; Céline Dupont; George Vartzelis; Aurélien Trimouille; Eléonore Eymard-Pierre; Mathilde Gay-Bellile; Florence Renaldo; Imen Dorboz; Cécile Pagan; Samuel Quentin; Monique Elmaleh; Christina Kotsogianni; Elissavet Konstantelou; Séverine Drunat; Anne-Claude Tabet; Odile Boespflug-Tanguy
Journal:  BMC Med Genet       Date:  2015-09-02       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.